BV3.DE 25.3 (-3.8%)
DK0015998017BiotechnologyBiotechnology

Bavarian Nordic (BV3.DE) Stock Highlights

25.3 | -3.8%
2023-08-17 06:45:04
Bavarian Nordic A/S is a biotechnology company focused on the development, manufacturing, and commercialization of cancer immunotherapies and vaccines for infectious diseases. The company has a specific focus on diseases for which the unmet medical need is high. Bavarian generates revenue through government research and development and supply contracts, and from its commercial partnerships. The vast majority of the companys revenue is generated in the Netherlands, followed by the United States, Canada, and other geographic markets.

Statistics

Range Today
25 25.73
Volume Today 661
Range 1 Year
23.12 55.1
Volume 1 Year 935.54K
Range 3 Year
16.92 55.1
Volume 3 Year 1.4M
Range 10 Year
16.92 55.1
Volume 10 Year 1.4M

Highlights

Market Capitalization 2.17B (mid)
Floating Shares 76.14M
Current Price 25.3
Price To Earnings 45.95
Price To Revenue -0.03
Price To Book 0.19
Earnings Per Share 0.56

Performance

Latest -3.8%
1 Month -7.29%
3 Months -3.44%
6 Months -24.93%
1 Year -22.56%
3 Years -15.07%
5 Years -15.07%
10 Years -15.07%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.